Search

everythinglearnresearchcommunity

for

Search:↓

Nanocarrier-based treatments show promise for better hair growth in androgenetic alopecia but need more research.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Selective breeding can enhance immunity in dairy cattle.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Dutasteride is the most effective hair loss treatment after 24 weeks, but finasteride leads to the most hair growth after 48 weeks.

A mix of specific inhibitors and a growth factor helps keep hair growth cells from losing their properties in the lab.

Younger mice's hair-follicle stem cells are better at turning into heart cells than older mice's.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Older patients sticking to their prostate medication saw lasting health benefits.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Potential new drugs for treating PCOS were identified.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

Tamsulosin increases the risk of floppy iris during eye surgery.

Eriocitrin and silymarin might be effective for hair loss treatment and need more research.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.